PMID: 6163628Jan 1, 1981Paper

Anti-mitogenic function of interferon-induced (2'-5')oligo(adenylate) and growth-related variations in enzymes that synthesize and degrade this oligonucleotide

European Journal of Biochemistry
A KimchiM Revel

Abstract

Addition of (2'5')ApApA to concanavalin-A-stimulated mouse spleen lymphocytes strongly inhibits the large increase in RNA and protein synthesis which takes place 24-48 h after stimulation. The inhibitory effect on protein synthesis precedes the effect on RNA synthesis and takes at least 6 h to be detected. Histone synthesis is preferentially inhibited at 48 h. No effect on protein synthesis was detected in unstimulated resting lymphocytes, or in stimulated lymphocytes during the first 24 h after concanavalin A treatment. The anti-mitogenic effect of the (2'-5')oligo(adenylate) seems to result, therefore, from inhibition of protein synthesis taking place before initiation of DNA replication. The mitogenic stimulus produced by the lectin enhances, in lymphocytes, the level of the 2'-phosphodiesterase which degrades (2'-5')oligo(adenylate). Enhancement of the 2'-phosphodiesterase was also observed after serum stimulation of confluent monkey kidney cells. Furthermore, the ratio of (2'-5')oligo(adenylate) synthetase to 2'-phosphodiesterase is ten-times lower in fast-growing kidney cells than in quiescent serum-starved cells. A model for the role of (2'-5')oligo(adenylate) synthesis and degradation in the regulation of cell prolifera...Continue Reading

References

Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A G HovanessianL Montagnier
Jan 1, 1979·Archives of Virology·E YakobsonD Gurari-Rotman
Jun 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·T W Nilsen, C Baglioni
Sep 1, 1979·FEBS Letters·B R WilliamsI M Kerr
Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A KimchiM Revel
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A SchmidtM Revel
Apr 15, 1977·International Journal of Cancer. Journal International Du Cancer·H Strander, S Einhorn
Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·I M Kerr, R E Brown
Mar 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·L A Ball, C N White
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·A ZilbersteinM Revel
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·E SlatteryP Lengyel
Jan 1, 1978·Annual Review of Biochemistry·A B PardeeR F Kletzien
Apr 13, 1979·Biochemical and Biophysical Research Communications·T SreevalsanE Rozengurt
Aug 24, 1978·Nature·F Balkwill, J Taylor-Papadimitriou
Sep 15, 1978·International Journal of Cancer. Journal International Du Cancer·F BalkwillJ Taylor-Papadimitriou
Apr 1, 1977·Journal of the National Cancer Institute·A Fuse, T Kuwata
Jan 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·H D Robertson, M B Mathews
Apr 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·B G PogoA E Mirsky
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A A CreaseyT C Merigan
Feb 1, 1980·Virology·A G Hovanessian, J N Wood

❮ Previous
Next ❯

Citations

May 1, 1989·Biological Reviews of the Cambridge Philosophical Society·T Alderson
Nov 16, 1987·European Journal of Biochemistry·M A TrujilloH V Rickenberg
Jan 1, 1984·Neurosurgical Review·M Nagai, T Arai
Feb 15, 1994·European Journal of Biochemistry·E I BudowskyY A Strelenko
Jan 20, 2011·Nucleic Acids Research·Jesper Buchhave PoulsenPia Møller Martensen
Feb 1, 1983·European Journal of Biochemistry·M Smekens-EtienneJ E Dumont
Aug 1, 1982·European Journal of Biochemistry·R H SilvermanI M Kerr
May 1, 1984·Somatic Cell and Molecular Genetics·L M ShulmanF H Ruddle
Dec 1, 1990·Journal of Interferon Research·E C BordenA P Teitelbaum
Apr 15, 1983·European Journal of Biochemistry·M C HaughI M Kerr
Sep 2, 1985·European Journal of Biochemistry·B BayardB Lebleu
Sep 1, 1982·European Journal of Biochemistry·M Verhaegen-Lewalle, J Content
May 20, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·D Rebouillat, A G Hovanessian
Jan 1, 1984·Human Genetics·P HerrlichH J Rahmsdorf
Dec 1, 1989·Journal of Interferon Research·B T BosworthM I Johnston
Jan 1, 1987·Journal of Toxicology and Environmental Health·D K Liu, G F Owens
Jun 1, 1991·Journal of Interferon Research·F J CastoraP F Torrence
Jun 12, 1998·Pharmacology & Therapeutics·M R Player, P F Torrence
Dec 1, 1988·Biochimie·M A TrujilloH L Cailla
Oct 18, 1983·Biochimica Et Biophysica Acta·T J BorelliJ M Wu
May 1, 1983·Molecular and Cellular Biology·A A CreaseyT C Merigan

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.